Clinical Trial Update: Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Frexalimab (SAR441344)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: RECRUITING